You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
三鑫醫療(300453.SZ):成都威力生被認定為2022年度四川省專精特新中小企業
格隆匯 11-15 18:14

格隆匯11月15日丨三鑫醫療(300453.SZ)公佈,根據四川省經濟和信息化廳近日發佈的《關於公佈2022年度四川省“專精特新”中小企業及通過複核企業名單的通知》(川經信企業函〔2022〕821號),公司全資子公司四川威力生醫療科技有限公司控股的子公司成都威力生生物科技有限公司(簡稱“成都威力生”)被認定為2022年度四川省“專精特新”中小企業,有效期三年。

此次成都威力生被認定為“專精特新”中小企業,是對其技術水平、創新能力、經營能力、發展前景等方面的認可,也是對其堅持科技創新的高度肯定,有利於提升成都威力生在行業的影響力和品牌形象,進一步增強其市場競爭力,對公司的長遠發展產生積極作用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account